Latest breakthroughs in HR+ breast cancer treatment from SABCS 2024, including oral SERDs, combination therapies, and precision medicine approaches.
Exploring environmental risk factors for breast cancer in Maceió through case-control studies, focusing on air pollutants, pesticides, and prevention strategies.
Discover how breast cancer treatment is being personalized for young patients based on hormone receptor status through landmark scientific analysis.
Discover how Telapristone acetate (CDB4124) disarms the progesterone receptor in breast cancer cells through a unique mechanism of action.
Explore how mouse models are driving groundbreaking discoveries in breast cancer research, from understanding relapse to developing new therapies.
Exploring de-escalated neoadjuvant therapy for HR+/HER2+ early breast cancer and the promising results of the WSG-ADAPT-TP trial.
Understanding the complex relationship between hormonal therapies and EGFR expression in breast cancer treatment and research.
Groundbreaking research shows how high-dose chemotherapy and targeted radiation can achieve unprecedented long-term results for oligometastatic breast cancer patients.
Exploring how the Oncotype DX test and SEER database are revolutionizing breast cancer treatment through genomic analysis and personalized medicine.
Exploring the relationship between androgen receptors and tumor-infiltrating lymphocytes across breast cancer subtypes and their clinical implications.